1)Bacharach J, Lee WW, Harrison AR et al:A review of acquired blepharoptosis:prevalence, diagnosis, and current treatment options. Eye(Lond) 35:2468-2481, 2021
2)Murai H, Yamashita N, Watanabe M et al:Characteristics of myasthenia gravis according to onset-age:Japanese nationwide survey. J Neurol Sci 305:97-102, 2011
3)de Meel RHP, Raadsheer WF, van Zwet EW et al:Ocular weakness in myasthenia gravis:changes in affected muscles are a distinct clinical feature. J Neuromuscul Dis 6:369-376, 2019
4)本村政勝:自己免疫性神経筋接合部疾患の病態と治療.臨床神経学51:872-876,2011
5)Mittal MK, Barohn RJ, Pasnoor M et al:Ocular myasthenia gravis in an academic neuro-ophthalmology clinic:clinical features and therapeutic response. J Clin Neuromuscul Dis 13:46-52, 2011
6)Golnik KC, Pena R, Lee AG et al:An ice test for the diagnosis of myasthenia gravis. Ophthalmology 106:1282-1286, 1999
7)Chatzistefanou KI, Kouris T, Iliakis E et al:The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology 116:2236-2243, 2009
8)Kupersmith MJ, Ying G:Ocular motor dysfunction and ptosis in ocular myasthenia gravis:effects of treatment. Br J Ophthalmol 89:1330-1334, 2005
9)Shimizu Y, Suzuki S, Utsugisawa K et al:Is surgical intervention safe and effective in the treatment of myasthenic blepharoptosis? A multicenter survey in Japan. Eur Neurol 71:259-261, 2014
10)Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E et al:Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease:a systematic review of the literature. Syst Rev 9:201, 2020
11)Eckstein AK, Lösch C, Glowacka D et al:Euthyroid and primary hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol 93:1052-1056, 2009
12)佐々木 悠・二田哲博・二宮 寛・他:病気の顔貌と容貌(6):甲状腺機能低下症(特に橋本病:Hashimoto's thyroiditis)について.健康科学13:165-176,1991